CY1116638T1 - Διαδερμικο θεραπευτικο συστημα για την χορηγηση μιας δραστικης ουσιας - Google Patents
Διαδερμικο θεραπευτικο συστημα για την χορηγηση μιας δραστικης ουσιαςInfo
- Publication number
- CY1116638T1 CY1116638T1 CY20151100738T CY151100738T CY1116638T1 CY 1116638 T1 CY1116638 T1 CY 1116638T1 CY 20151100738 T CY20151100738 T CY 20151100738T CY 151100738 T CY151100738 T CY 151100738T CY 1116638 T1 CY1116638 T1 CY 1116638T1
- Authority
- CY
- Cyprus
- Prior art keywords
- active substance
- administration
- therapeutic system
- interderative
- layer
- Prior art date
Links
- 239000013543 active substance Substances 0.000 title abstract 3
- 230000001225 therapeutic effect Effects 0.000 title abstract 2
- 239000010410 layer Substances 0.000 abstract 3
- 239000004821 Contact adhesive Substances 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- 239000012790 adhesive layer Substances 0.000 abstract 1
- 239000011247 coating layer Substances 0.000 abstract 1
- 239000011159 matrix material Substances 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 229920001083 polybutene Polymers 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/27—Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Emergency Medicine (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Psychiatry (AREA)
- Psychology (AREA)
- Hospice & Palliative Care (AREA)
- Inorganic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP10194968.3A EP2468274B1 (de) | 2010-12-14 | 2010-12-14 | Transdermales therapeutisches System zur Verabreichung eines Wirkstoffs |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CY1116638T1 true CY1116638T1 (el) | 2017-03-15 |
Family
ID=43836835
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CY20151100738T CY1116638T1 (el) | 2010-12-14 | 2015-08-25 | Διαδερμικο θεραπευτικο συστημα για την χορηγηση μιας δραστικης ουσιας |
| CY20201101121T CY1123712T1 (el) | 2010-12-14 | 2020-11-25 | Διαδερμικο θεραπευτικο συστημα για την χορηγηση μιας δραστικης ουσιας |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CY20201101121T CY1123712T1 (el) | 2010-12-14 | 2020-11-25 | Διαδερμικο θεραπευτικο συστημα για την χορηγηση μιας δραστικης ουσιας |
Country Status (25)
| Country | Link |
|---|---|
| US (2) | US10660863B2 (enExample) |
| EP (2) | EP2468274B1 (enExample) |
| JP (1) | JP6043296B2 (enExample) |
| KR (1) | KR101842309B1 (enExample) |
| CN (3) | CN107412202A (enExample) |
| AU (2) | AU2011343363B2 (enExample) |
| BR (1) | BR112013014616B1 (enExample) |
| CA (2) | CA2817461C (enExample) |
| CY (2) | CY1116638T1 (enExample) |
| DK (2) | DK2468274T3 (enExample) |
| EA (1) | EA026520B1 (enExample) |
| ES (2) | ES2545094T3 (enExample) |
| HK (1) | HK1243336A1 (enExample) |
| HR (2) | HRP20201880T1 (enExample) |
| HU (2) | HUE027916T2 (enExample) |
| LT (1) | LT2651410T (enExample) |
| MX (1) | MX345344B (enExample) |
| MY (1) | MY183873A (enExample) |
| PL (2) | PL2468274T3 (enExample) |
| PT (2) | PT2468274E (enExample) |
| RS (2) | RS54173B1 (enExample) |
| SI (2) | SI2468274T1 (enExample) |
| SM (2) | SMT202000638T1 (enExample) |
| WO (1) | WO2012080365A1 (enExample) |
| ZA (1) | ZA201303965B (enExample) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE102012000369A1 (de) * | 2012-01-11 | 2013-07-11 | Alfred E. Tiefenbacher (Gmbh & Co. Kg) | Transdermales therapeutisches System mit Cholinesterase-Hemmer |
| DE102012016317A1 (de) | 2012-08-14 | 2014-02-20 | Jenabatteries GmbH | Redox-Flow-Zelle zur Speicherung elektrischer Energie |
| EP2884969A1 (en) * | 2012-08-15 | 2015-06-24 | Dow Corning Corporation | Multi - layer transdermal drug delivery system |
| WO2014111790A2 (en) * | 2013-01-15 | 2014-07-24 | Zydus Technologies Limited | Stable transdermal pharmaceutical drug delivery system comprising rivastigmine |
| US20240082065A1 (en) * | 2016-07-08 | 2024-03-14 | Moteah Williams | Waterproof and transparent wound barrier and method of manufacturing same |
| CN109640976B (zh) | 2016-08-22 | 2023-10-17 | 救急药品工业株式会社 | 贴附剂 |
| JP7193863B2 (ja) * | 2017-07-19 | 2022-12-21 | 帝國製薬株式会社 | リバスチグミン含有経皮吸収型製剤 |
| DE102018120505A1 (de) * | 2017-10-20 | 2019-04-25 | Amw Gmbh | Verhinderung der Kristallisation von Wirkstoffen in transdermalen Darreichungssystemen |
| DE102017127433A1 (de) * | 2017-11-21 | 2019-05-23 | Lts Lohmann Therapie-Systeme Ag | TTS auf Basis von klebenden Weichmacher-Polymer-Matrices |
| BR112020018300A2 (pt) * | 2018-03-13 | 2020-12-22 | Lts Lohmann Therapie-Systeme Ag | Sistema terapêutico transdérmico compreendendo um polímero híbrido de silicone e acrílico |
| JP7170285B2 (ja) * | 2018-05-17 | 2022-11-14 | パナソニックＩｐマネジメント株式会社 | 生体貼付け用選択透過膜、経皮吸収キットおよび美容方法 |
| EP3871877A1 (en) | 2018-08-08 | 2021-09-01 | Danapak Flexibles A/S | Improved films and laminates for use in packaging reactive compounds |
| KR102710072B1 (ko) | 2018-08-31 | 2024-09-24 | 에스케이케미칼 주식회사 | 장기 투여용 리바스티그민 패취 |
| KR102823139B1 (ko) | 2018-08-31 | 2025-06-19 | 에스케이케미칼 주식회사 | 장기 투여용 리바스티그민 패취 |
| CN114007595A (zh) * | 2019-07-09 | 2022-02-01 | 罗曼治疗系统股份公司 | 包括包含丙烯酸类聚合物的含活性剂层和包含硅酮凝胶粘合剂的皮肤接触层的透皮治疗系统 |
| CN113616625B (zh) * | 2021-08-26 | 2023-05-30 | 大连科翔科技开发有限公司 | 一种卡巴拉汀的长效透皮贴剂 |
| DE102021128912A1 (de) * | 2021-11-05 | 2023-05-11 | Lts Lohmann Therapie-Systeme Ag. | Okklusives pflaster mit flexibler backing |
Family Cites Families (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HU201906B (en) | 1987-03-04 | 1991-01-28 | Sandoz Ag | Process for producing phenyl-carbamate derivative and acid additional salts and pharmaceutical compositions containing them |
| EP0656771A4 (en) * | 1992-08-25 | 1996-07-31 | Cygnus Therapeutic Systems | DEVICE FOR TRANSDERMAL DRUG DELIVERY. |
| JPH0912448A (ja) * | 1995-04-28 | 1997-01-14 | Read Chem Kk | 薬物放出制御型経皮吸収製剤 |
| GB9800526D0 (en) | 1998-01-12 | 1998-03-11 | Ciba Geigy Ag | Organic compounds |
| US6348210B1 (en) * | 1998-11-13 | 2002-02-19 | Alza Corporation | Methods for transdermal drug administration |
| DE19918106A1 (de) * | 1999-04-22 | 2000-10-26 | Lohmann Therapie Syst Lts | Transdermales therapeutisches System mit neutralisierten Acrylathaftklebern |
| DE10033853A1 (de) | 2000-07-12 | 2002-01-31 | Hexal Ag | Transdermales therapeutisches System mit hochdispersem Siliziumdioxid |
| DE10103860B4 (de) * | 2001-01-30 | 2004-12-23 | Lts Lohmann Therapie-Systeme Ag | Transdermales therapeutisches System für die Verabreichung carboxylgruppenhaltiger, nichtsteroidaler Antiphlogistika, sowie Verfahren zu seiner Herstellung |
| DE10141650C1 (de) * | 2001-08-24 | 2002-11-28 | Lohmann Therapie Syst Lts | Transdermales Therapeutisches System mit Fentanyl bzw. verwandten Substanzen |
| DE10141652B4 (de) | 2001-08-24 | 2011-04-07 | Lts Lohmann Therapie-Systeme Ag | Transdermales therapeutisches System auf der Basis von Polyacrylat-Haftklebern ohne funktionelle Gruppen und seine Verwendung |
| US8252319B2 (en) * | 2004-10-21 | 2012-08-28 | Durect Corporation | Transdermal delivery system for sufentanil |
| CA2583642C (en) * | 2004-10-21 | 2013-06-25 | Durect Corporation | Transdermal delivery systems |
| TWI389709B (zh) * | 2005-12-01 | 2013-03-21 | Novartis Ag | 經皮治療系統 |
| WO2007076862A1 (en) * | 2005-12-30 | 2007-07-12 | Coloplast A/S | A layered adhesive construct having a mouldable layer as skin contact surface |
| CN101304735A (zh) * | 2006-01-12 | 2008-11-12 | Lts勒曼治疗系统股份公司 | 用于挥发性和/或热不稳定的物质的经皮治疗体系 |
| BRPI0621655A2 (pt) * | 2006-05-08 | 2011-12-20 | Teikoku Seiyaku Kk | preparação para a absorção percutánea de uma droga antidemência básica |
| US9248104B2 (en) * | 2006-08-17 | 2016-02-02 | Core Tech Solutions, Inc. | Transdermal methods and systems for treating Alzheimer's disease |
| DE102006054731B4 (de) * | 2006-11-21 | 2013-02-28 | Lts Lohmann Therapie-Systeme Ag | Transdermales therapeutisches System zur Verabreichung des Wirkstoffs Buprenorphin und Verwendung desselben in der Schmerztherapie |
| US20100292660A1 (en) | 2007-07-10 | 2010-11-18 | Agis Kydonieus | Dermal delivery device with ultrasonic weld |
| WO2009026135A2 (en) * | 2007-08-17 | 2009-02-26 | Alza Corporation | Controlled transdermal bisoprolol delivery system |
| US9155725B2 (en) * | 2008-02-27 | 2015-10-13 | Hisamitsu Pharmaceutical Co., Inc. | Adhesive skin patch and packaged product |
| US20090291127A1 (en) * | 2008-05-21 | 2009-11-26 | Jianye Wen | Transdermal anti-dementia active agent formulations and methods for using the same |
| JP2010126450A (ja) * | 2008-11-25 | 2010-06-10 | Lintec Corp | 経皮吸収貼付剤 |
| WO2011076621A2 (de) * | 2009-12-22 | 2011-06-30 | Acino Ag | Transdermales therapeutisches system zur verabreichung von rivastigmin oder dessen derivaten |
-
2010
- 2010-12-14 ES ES10194968.3T patent/ES2545094T3/es active Active
- 2010-12-14 PT PT101949683T patent/PT2468274E/pt unknown
- 2010-12-14 EP EP10194968.3A patent/EP2468274B1/de active Active
- 2010-12-14 SI SI201031006T patent/SI2468274T1/sl unknown
- 2010-12-14 DK DK10194968.3T patent/DK2468274T3/en active
- 2010-12-14 HU HUE10194968A patent/HUE027916T2/en unknown
- 2010-12-14 RS RS20150562A patent/RS54173B1/sr unknown
- 2010-12-14 PL PL10194968T patent/PL2468274T3/pl unknown
-
2011
- 2011-12-14 ES ES11799413T patent/ES2836483T3/es active Active
- 2011-12-14 EA EA201300704A patent/EA026520B1/ru not_active IP Right Cessation
- 2011-12-14 MY MYPI2013001975A patent/MY183873A/en unknown
- 2011-12-14 EP EP11799413.7A patent/EP2651410B1/de active Active
- 2011-12-14 WO PCT/EP2011/072812 patent/WO2012080365A1/de not_active Ceased
- 2011-12-14 HU HUE11799413A patent/HUE052137T2/hu unknown
- 2011-12-14 PT PT117994137T patent/PT2651410T/pt unknown
- 2011-12-14 CA CA2817461A patent/CA2817461C/en active Active
- 2011-12-14 LT LTEP11799413.7T patent/LT2651410T/lt unknown
- 2011-12-14 CN CN201710451001.1A patent/CN107412202A/zh active Pending
- 2011-12-14 US US13/994,242 patent/US10660863B2/en active Active
- 2011-12-14 AU AU2011343363A patent/AU2011343363B2/en active Active
- 2011-12-14 MX MX2013005581A patent/MX345344B/es active IP Right Grant
- 2011-12-14 RS RS20201478A patent/RS61155B1/sr unknown
- 2011-12-14 SM SM20200638T patent/SMT202000638T1/it unknown
- 2011-12-14 JP JP2013543774A patent/JP6043296B2/ja active Active
- 2011-12-14 SI SI201131933T patent/SI2651410T1/sl unknown
- 2011-12-14 CN CN201180059614.1A patent/CN103269698B/zh active Active
- 2011-12-14 CN CN202110438860.3A patent/CN113244199A/zh active Pending
- 2011-12-14 PL PL11799413T patent/PL2651410T3/pl unknown
- 2011-12-14 CA CA3065240A patent/CA3065240C/en active Active
- 2011-12-14 BR BR112013014616-8A patent/BR112013014616B1/pt active IP Right Grant
- 2011-12-14 KR KR1020137016047A patent/KR101842309B1/ko active Active
- 2011-12-14 HR HRP20201880TT patent/HRP20201880T1/hr unknown
- 2011-12-14 DK DK11799413.7T patent/DK2651410T3/da active
-
2013
- 2013-05-30 ZA ZA2013/03965A patent/ZA201303965B/en unknown
-
2015
- 2015-07-31 SM SM201500184T patent/SMT201500184B/xx unknown
- 2015-08-19 HR HRP20150881TT patent/HRP20150881T1/hr unknown
- 2015-08-25 CY CY20151100738T patent/CY1116638T1/el unknown
-
2017
- 2017-08-11 AU AU2017213569A patent/AU2017213569B2/en active Active
-
2018
- 2018-02-28 HK HK18102858.7A patent/HK1243336A1/zh unknown
-
2020
- 2020-04-28 US US16/860,210 patent/US20200289426A1/en not_active Abandoned
- 2020-11-25 CY CY20201101121T patent/CY1123712T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1123712T1 (el) | Διαδερμικο θεραπευτικο συστημα για την χορηγηση μιας δραστικης ουσιας | |
| CY1120283T1 (el) | Διαδερμικο θεραπευτικο συστημα για την χορηγηση ριβαστιγμινης ή παραγωγων αυτης | |
| EP2589379A4 (en) | TRANSDERMAL DRUG DELIVERY SYSTEM CONTAINING DEPPEZIL | |
| BR112012024835A2 (pt) | adesivo de distribuição transdérmica | |
| CY1116111T1 (el) | Τοπικη συνθεση για τη θεραπεια της ακτινικης κερατωσης | |
| CL2011000935A1 (es) | Composicion farmaceutica que comprende acetaminofeno y un material de tramadol complejo, que exhibe una liberacion sostenida y coordinada a traves de una capa de liberacion sostenida y otra de liberacion inmediata; metodo de preparacion;y el uso de un material complejo de tramadol y acetaminofeno para preparar un medicamento para el tratamiento del dolor. | |
| CL2015003377A1 (es) | Sistema de liberación transdérmico. | |
| CR20150360A (es) | Sistema de liberación transdérmica | |
| IN2012DN01225A (enExample) | ||
| EA201400628A1 (ru) | Трансдермальная терапевтическая система для введения фентанила или его аналога | |
| MX2018008467A (es) | Composiciones de gel para administracion transdermica para maximizar las concentraciones de farmaco en el estrato corneo y suero, y metodos de uso de las mismas. | |
| CY1123805T1 (el) | Διαδερμικο σκευασμα που περιεχει αναστολεις cox | |
| PH12012501523A1 (en) | Dental strip for administration of oral treatment | |
| AR070031A1 (es) | Sistemas de administracion transdermicos de droga ketotifen y metodos para el tratamiento de enfermedades oftalmicas | |
| AR094289A1 (es) | Sistemas de administracion transdermica de farmacos para levonorgestrel y etinil estradiol | |
| CY1124303T1 (el) | Διαδερμικο θεραπευτικο συστημα με καλυπτικη ταινια, που περιλαμβανει δυο συγκολλητικα στρωματα | |
| DOP2014000171A (es) | Sistema para la administración de fármacos | |
| EA201300648A1 (ru) | Трансдермальная терапевтическая система (tts), содержащая ротиготин | |
| BR112012014107A2 (pt) | sistema terapêutico transdérmico para administração de peptídeos | |
| MY166972A (en) | Transdermal delivery system containing galantamine or salts thereof | |
| MX2015010967A (es) | Formulaciones transdermicas de laquinimod. | |
| ATE551977T1 (de) | Pflaster | |
| CY1122538T1 (el) | Συμπλεγματα χονδροϊτινης για διαδερμικη απορροφηση | |
| TR201101809A1 (tr) | Vildagliptin ve glimepirid kombinasyonları. | |
| CY1119228T1 (el) | Ιατρικα δραστικο εμπλαστρο |